BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Palmeri R, Lo Buono V, Bonanno L, Sorbera C, Cimino V, Bramanti P, Di Lorenzo G, Marino S. Potential predictors of quality of life in Parkinson’s Disease: Sleep and mood disorders. Journal of Clinical Neuroscience 2019;70:113-7. [DOI: 10.1016/j.jocn.2019.08.058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Yang Y, Pan A, Xu Z, Wang L, Zhang Y, Nie K, Huang B. Identifying Depression in Parkinson's Disease by Using Combined Diffusion Tensor Imaging and Support Vector Machine. Front Neurol 2022;13:878691. [DOI: 10.3389/fneur.2022.878691] [Reference Citation Analysis]
2 Zhang L, Chen Y, Liang X, Wang L, Wang J, Tang Y, Zhu X. Prediction of Quality of Life in Patients With Parkinson’s Disease With and Without Excessive Daytime Sleepiness: A Longitudinal Study. Front Aging Neurosci 2022;14:846563. [DOI: 10.3389/fnagi.2022.846563] [Reference Citation Analysis]
3 Stathis P, Papadopoulos G. Evaluation and validation of a patient-reported quality-of-life questionnaire for Parkinson's disease. J Patient Rep Outcomes 2022;6:17. [PMID: 35235090 DOI: 10.1186/s41687-022-00427-0] [Reference Citation Analysis]
4 Liguori C, De Franco V, Cerroni R, Spanetta M, Mercuri NB, Stefani A, Pierantozzi M, Di Pucchio A. Sleep problems affect quality of life in Parkinson's disease along disease progression. Sleep Med 2021;81:307-11. [PMID: 33756280 DOI: 10.1016/j.sleep.2021.02.036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Crispino P, Gino M, Barbagelata E, Ciarambino T, Politi C, Ambrosino I, Ragusa R, Marranzano M, Biondi A, Vacante M. Gender Differences and Quality of Life in Parkinson's Disease. Int J Environ Res Public Health 2020;18:E198. [PMID: 33383855 DOI: 10.3390/ijerph18010198] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
6 Jenner P, Mori A, Kanda T. Can adenosine A2A receptor antagonists be used to treat cognitive impairment, depression or excessive sleepiness in Parkinson's disease? Parkinsonism & Related Disorders 2020;80:S28-36. [DOI: 10.1016/j.parkreldis.2020.09.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
7 Santos-garcía D, Castro ES, de Deus Fonticoba T, Panceiras MJF, Enriquez JGM, González JMP, Bartolomé CC, Planellas LL, Caldentey JG, Caballol N, Legarda I, López IC, Manzanares LL, Rivera MAÁ, Catalán MJ, Nogueira V, Borrué C, Sauco MÁ, Vela L, Cubo E, Castrillo JCM, Alonso PS, Losada MGA, Ariztegui NL, Gastón MI, Kulisevsky J, Pagonabarraga J, Seijo M, Martínez JR, Valero C, Kurtis M, Ardura JG, Prieto C, Mir P, Martinez-martin P. Sleep Problems Are Related to a Worse Quality of Life and a Greater Non-Motor Symptoms Burden in Parkinson’s Disease. J Geriatr Psychiatry Neurol. [DOI: 10.1177/0891988720964250] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
8 Zuzuárregui JRP, During EH. Sleep Issues in Parkinson's Disease and Their Management. Neurotherapeutics 2020;17:1480-94. [PMID: 33029723 DOI: 10.1007/s13311-020-00938-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]